UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy

[PainDoc2025]

---

Members don't see this ad.

Article: Nevro Announces UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy
Research: Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

Thoughts? Seems like good news. And also an interesting use case of SCS for those who haven't read the JAMA article.

 

[Agast]

I’ll be curious what percentage of these patients still like their stimulators at the 5 year mark

 

[RoloTomassi]

I’ll be curious what percentage of these patients still like their stimulators at the 5 year mark

They'll be explanted for infection before then

 

[drusso]

#Gamechanger #OpioidSparingTreatment #PatientsMatter #OutcomesMatter #FutureIsBright #AdvancingOurField

 

[Orin]

I’ll be curious what percentage of these patients still like their stimulators at the 5 year mark

Severity of Neuropathy Is Associated With Long-term Spinal Cord Stimulation Outcome in Painful Diabetic Peripheral Neuropathy: Five-Year Follow-up of a Prospective Two-Center Clinical Trial - PubMed

SCS is successful in reducing chronic pain symptoms in the lower extremities of patients with PDPN up to 5 years after initiation of treatment. Furthermore, 80% of patients with PDPN still use their SCS device after 5 years. Moreover, the severity of neuropathy is associated with a higher chance...

pubmed.ncbi.nlm.nih.gov

"Results: Treatment success was observed in 55% of patients after 5 years. Median duration of SCS treatment was 60 months (minimum 1 month, maximum 60 months), and 80% of patients with a permanent implant still used their SCS device after 5 years. Higher MDNS was associated with treatment failure during the 5-year follow-up (hazard ratio 3.9 [95% CI 1.3-11.6]; P = 0.014)."

Caveat here is this is not with HF10 stimulation, but this should in theory be the floor.

 

[Agast]

Severity of Neuropathy Is Associated With Long-term Spinal Cord Stimulation Outcome in Painful Diabetic Peripheral Neuropathy: Five-Year Follow-up of a Prospective Two-Center Clinical Trial - PubMed

SCS is successful in reducing chronic pain symptoms in the lower extremities of patients with PDPN up to 5 years after initiation of treatment. Furthermore, 80% of patients with PDPN still use their SCS device after 5 years. Moreover, the severity of neuropathy is associated with a higher chance...

pubmed.ncbi.nlm.nih.gov

"Results: Treatment success was observed in 55% of patients after 5 years. Median duration of SCS treatment was 60 months (minimum 1 month, maximum 60 months), and 80% of patients with a permanent implant still used their SCS device after 5 years. Higher MDNS was associated with treatment failure during the 5-year follow-up (hazard ratio 3.9 [95% CI 1.3-11.6]; P = 0.014)."

Caveat here is this is not with HF10 stimulation, but this should in theory be the floor.

55% treatment success ugh

So in practice we will probably see closer to 33%

 

[Dr. Ice]

I’ll be curious what percentage of these patients still like their stimulators at the 5 year mark

0%